Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.

by Marci A. Landsmann

A study suggests that 3-D mammograms may reduce unnecessary biopsies, and the U.S. Food and Drug Administration issues warnings to breast implant companies.

by Kate Yandell

NCI director steps in as FDA commissioner, new guidelines on clinical trial eligibility, and health risks for childhood cancer survivors.

by Bradley Jones

FDA Commissioner Scott Gottlieb resigns, an analysis explores patient advocacy groups' financial ties, and Alex Trebek announces he has pancreatic cancer.

by Marci A. Landsmann

A blood test for tumor mutations shows promise as an option for lung cancer patients, and the U.S. Food and Drug Administration expresses concern about robotically-assisted cancer surgery.

by Kate Yandell

Trials indicate that a combination of a targeted therapy and immunotherapy can treat advanced kidney cancer, and a study identifies a genetic variant associated with smoking menthol cigarettes.

by Kate Yandell

Guidelines recommend that all breast cancer patients be offered genetic testing, and a report indicates that disparities in cancer incidence and mortality between black and white Americans are getting smaller.

by Kate Yandell

A study finds that a new shingles vaccine is safe and likely effective in adult cancer patients, and a review article shows that some cancer patients with HIV can benefit from immunotherapy.

by Kate Yandell

Unsupported claims of a “complete cure” for cancer spread across the internet and airwaves, and a new policy aims to increase inclusion of older patients in research.

by Kate Yandell

A trial finds that it is safe to take a hormone-blocking drug to reduce prostate cancer risk, and direct-to-consumer genetic testing for cancer risk factors expands.

by Kate Yandell